Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Daxor Corporation DXR

Set alert

Price alert · DXR

All alert types
8.95 USD -0.05 -0.56%

As of Nov 3, 9:53 AM ET

Bid
8.87 × 1
Ask
8.96 × 5
8.89 Day range 8.95
8.40 52-week range 14.76
YTD
-39.32%
1 year
-31.63%
Open
8.89
Prev close
9.00
Mkt cap
52.25M
Vol
3.94K
Avg vol
20.03K
EPS
1.10
P/E
8.14
Div yield
0.00%
More statistics
Low
8.89
High
8.95
Forward P/E
0.00
Beta
-0.54
Short ratio
0.60
Inst. own
1.94%
Dividend
0.00
Ex-div date
Jan 4, 2018
Earnings
Mar 28, 2012
50-d avg
8.96
200-d avg
9.04
1y target
23.38

3M chart

Chart tools
Interval
1m5m15m30m

Signals (18)
NameDateAgo
RSI: OversoldOct 23, 20261 week ago
SMA: BearishOct 2, 20261 month ago
SMA: BearishOct 2, 20261 month ago
MACD: Sell SignalSep 30, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 25, 20261 month ago
SMA: BullishSep 8, 20261 month ago
SMA: BullishSep 8, 20261 month ago
SMA: BearishSep 4, 20262 months ago
SMA: BearishSep 4, 20262 months ago
SMA: BullishSep 1, 20262 months ago
SMA: BullishSep 1, 20262 months ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 7, 20262 months ago

Key statistics

Financials
Market cap
40.17M
Enterprise value
0
Trailing P/E
7.16
Forward P/E
0.00
PEG ratio
0.00
Price / sales
260.51
Price / book
1.23
EPS (TTM)
1.16
Beta
-0.54
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1094.00%
Revenue (TTM)
154.21K
Revenue growth
-11.40%
Free cash flow
0
Total cash
0
Total debt
1.65M
Return on equity
5.35%
Shares outstanding
4.84M
Short % of float
0.71%
50-day average
8.96
200-day average
9.04

Analyst view

Consensus: none

Price target (mean) 23.38 +161.2% upside
Target (low)
22.00
Target (mean)
23.38
Target (high)
24.75
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Mar 28, 2012

Expected Mar 28, 2012. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
DXR Revenue — quarterly 369.83K
2008-Q1 20082008-Q2 20082008-Q3 20082008-Q4 20082009-Q1 20092009-Q2 20092009-Q3 20092009-Q4 20092010-Q1 20102010-Q2 20102010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 2011
DXR Net income — quarterly -1.49M
2008-Q1 20082008-Q2 20082008-Q3 20082008-Q4 20082009-Q1 20092009-Q2 20092009-Q3 20092009-Q4 20092010-Q1 20102010-Q2 20102010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 2011
DXR EPS — quarterly -0.36
2008-Q1 20082008-Q2 20082008-Q3 20082008-Q4 20082009-Q1 20092009-Q2 20092009-Q3 20092009-Q4 20092010-Q1 20102010-Q2 20102010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 2011

Earnings

DXR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 28, 2012Dec 1, 20110.00———
Nov 14, 2011Sep 1, 20110.00———

Upgrades / downgrades

DXR analyst upgrades and downgrades
DateFirmActionFromTo
Sep 9, 2024Ascendiant CapitalmainBuyBuy
Jul 29, 2019Maxim Groupinit—Buy
May 16, 2019Ascendiant Capitalinit—Buy

About Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
daxor.com

News

All news

Your note

Sign in to keep a note on DXR — it syncs with the Stock Master app.

Insider holders

DXR insider holders
InsiderRelationLatest transactionDateShares held
FELDSCHUH JONATHAN ADAMOfficer and DirectorPurchaseDec 5, 202435,908
FELDSCHUH MICHAEL RICHARDChief Executive OfficerPurchaseDec 5, 2024207,492
FEUER EDWARDDirectorPurchaseMar 3, 20241,000
GOUDIE JOY SDirectorPurchaseMay 23, 2023300
JOSEPH FELDSCHUH UEOTrusteeStock GiftSep 17, 20232,549,460
MICHEL ROBERT JChief Financial OfficerPurchaseMar 26, 202411,300

Institution ownership

DXR institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc1.01%48,828405.27KSep 29, 2024
Renaissance Technologies, LLC0.31%14,821123.01KSep 29, 2024
Keyes, Stange & Wooten Wealth Management, LLC 0.30%14,612121.28KSep 29, 2024
Osaic Holdings Inc0.15%7,20059.76KSep 29, 2024
UBS Group AG0.03%1,23610.26KSep 29, 2024
Princeton Global Asset Management LLC0.01%5004.15KSep 29, 2024

Fund ownership

DXR fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.01%48,828405.27KSep 29, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.13%6,30552.33KSep 29, 2024
Gabelli Global Mini Mites Fund0.01%4003.32KSep 29, 2024
Northern Small Cap Core Fund0.00%37307Sep 29, 2024

Dividends

DXR recent dividends
Ex-dividend dateAmount
Jan 5, 20180.03
Dec 20, 20170.03
Dec 20, 20160.03
Dec 18, 20150.04
Dec 4, 20140.03
Dec 5, 20130.05